These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 10428734

  • 1. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L, Sinding J, Raskin P.
    Ann Intern Med; 1999 Aug 03; 131(3):182-8. PubMed ID: 10428734
    [Abstract] [Full Text] [Related]

  • 2. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb 01; 128(3):165-75. PubMed ID: 9454524
    [Abstract] [Full Text] [Related]

  • 3. Combination of insulin and metformin in the treatment of type 2 diabetes.
    Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD.
    Diabetes Care; 2002 Dec 01; 25(12):2133-40. PubMed ID: 12453950
    [Abstract] [Full Text] [Related]

  • 4. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A, Schmülling RM, Häring HU, Stumvoll M.
    Acta Diabetol; 2000 Mar 01; 37(1):13-8. PubMed ID: 10928231
    [Abstract] [Full Text] [Related]

  • 5. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V, Rosenstock J, Patwardhan R, Salzman A.
    JAMA; 2000 Apr 05; 283(13):1695-702. PubMed ID: 10755495
    [Abstract] [Full Text] [Related]

  • 6. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M.
    Ann Intern Med; 1999 Mar 02; 130(5):389-96. PubMed ID: 10068412
    [Abstract] [Full Text] [Related]

  • 7. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.
    Diabetes Care; 1998 May 02; 21(5):701-5. PubMed ID: 9589227
    [Abstract] [Full Text] [Related]

  • 8. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
    Douek IF, Allen SE, Ewings P, Gale EA, Bingley PJ, Metformin Trial Group.
    Diabet Med; 2005 May 02; 22(5):634-40. PubMed ID: 15842521
    [Abstract] [Full Text] [Related]

  • 9. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M, Bursey D.
    Pediatrics; 2001 Apr 02; 107(4):E55. PubMed ID: 11335776
    [Abstract] [Full Text] [Related]

  • 10. Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy.
    Berhanu P, Perez A, Yu S.
    Diabetes Obes Metab; 2007 Jul 02; 9(4):512-20. PubMed ID: 17587394
    [Abstract] [Full Text] [Related]

  • 11. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
    Out M, Miedema I, Jager-Wittenaar H, van der Schans C, Krijnen W, Lehert P, Stehouwer C, Kooy A.
    Diabetes Obes Metab; 2018 Jan 02; 20(1):219-223. PubMed ID: 28681986
    [Abstract] [Full Text] [Related]

  • 12. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
    Derosa G, Franzetti IG, Querci F, Carbone A, Ciccarelli L, Piccinni MN, Fogari E, Maffioli P.
    Pharmacotherapy; 2013 Aug 02; 33(8):817-26. PubMed ID: 23744726
    [Abstract] [Full Text] [Related]

  • 13. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J, Fonseca VA, Garvey WT, Goldberg RB, Handelsman Y, Abby SL, Lai YL, Jin X, Misir S, Nagendran S, Jones MR.
    Endocr Pract; 2010 Aug 02; 16(4):629-40. PubMed ID: 20634175
    [Abstract] [Full Text] [Related]

  • 14. Liraglutide in Children and Adolescents with Type 2 Diabetes.
    Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T, Ellipse Trial Investigators.
    N Engl J Med; 2019 Aug 15; 381(7):637-646. PubMed ID: 31034184
    [Abstract] [Full Text] [Related]

  • 15. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ, T1D Exchange Clinic Network Metformin RCT Study Group.
    JAMA; 2015 Dec 01; 314(21):2241-50. PubMed ID: 26624824
    [Abstract] [Full Text] [Related]

  • 16. Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients.
    Hermann LS, Kalén J, Katzman P, Lager I, Nilsson A, Norrhamn O, Sartor G, Ugander L.
    Diabetes Obes Metab; 2001 Dec 01; 3(6):428-34. PubMed ID: 11903415
    [Abstract] [Full Text] [Related]

  • 17. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE.
    Endocr Pract; 2011 Dec 01; 17(6):933-8. PubMed ID: 21856592
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
    Schernthaner G, Matthews DR, Charbonnel B, Hanefeld M, Brunetti P, Quartet [corrected] Study Group.
    J Clin Endocrinol Metab; 2004 Dec 01; 89(12):6068-76. PubMed ID: 15579760
    [Abstract] [Full Text] [Related]

  • 19. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G, Franzetti I, Querci F, D'Angelo A, Maffioli P.
    Pharmacotherapy; 2015 Nov 01; 35(11):983-90. PubMed ID: 26598090
    [Abstract] [Full Text] [Related]

  • 20. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun 01; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.